The Official CORMEDIX (CRMD)thread (run up to FDA approval has begun )

[Tug life]

I introduced Cormedix another thread but it seems to have taken a life of its own. Here I will compile all the info on this company and why I believe we can make a lot of money from it.

The Company seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of infectious and inflammatory diseases. CorMedix’s first commercial product in Europe is Neutrolin®, a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients, in addition to oncology patients, critical care patients, and patients receiving total parenteral nutrition, IV hydration, and/or IV medications. The FDA has granted Fast Track status to Neutrolin Catheter Lock Solution and also had designated Neutrolin as a Qualified Infectious Disease Product for oncology, hemodialysis, and critical care/intensive care patients, where catheter-related blood stream infections and clotting can be life-threatening. The initial and planned indications aim to address significant needs in catheter-based treatments in the U.S. and the rest of the world.

Results from their most recent study
Yahoo is now part of Oath

MUST WATCH! Great video explaining the company and its potential



Some bullet points.
Cormedix is 71% more effective in reducing catheter related infections than the current standard of care which is herapin owned by Pfizer.

P Value is extremely low at 0.0006 which basically means that if they did the study 10,000 more times the chance of getting different results will be 6 out of 10,000 trails

Nuetrolin is already approved and selling in Europe

Trail were halted last year by the FDA for efficiency.

 

[Clark Wayne]

Appreciate the heads up fam.

I been focusing on blue chips and some REITS but I do need some stocks for growth.

 

[Tug life]

Good read on Cormedix today
CorMedix (CRMD) Stock: The Dip May Be An Opportunity





Home Biotech Stocks

• Biotech Stocks

CorMedix (CRMD) Stock: The Dip May Be An Opportunity
By
Joshua Rodriguez
-
March 18, 2019
0

CorMedix Inc. (NYSEAMERICAN: CRMD) is falling hard in the market this morning. However, with no negative news hitting the wire, many are wondering the reason for the fall and whether or not buying now is simply a discounted opportunity for future gains. Today, we’ll talk about:

• Why today’s dip in CRMD stock values could be an opportunity;
• what we’re seeing from the stock; and
• what we’ll be watching for ahead.

Why CRMD May Be A Big Opportunity
As mentioned above, CorMedix isn’t having the best of days in the market today. Unfortunately, with no news released by the company and nothing hitting the media wire elsewhere, the reason for the gains is hard to pin down.

Nonetheless, this may be a great opportunity. The truth of the matter is that there’s good reason to be excited about CRMD for the long run. The company’s flagship candidate, Neutrolin, may be one of incredibly high value.

Neutrolin is a catheter lock solution. The solution has been shown to produce overwhelmingly positive results in various clinical trials to date. The data shows that Neutrolin is effective in the prevention of infections associated with intravenous catheters.

This could prove to be a very valuable product. After all, the venous catheter market is a massive one and is growing quickly. At the moment, the compound annual growth rate of the market sits at above 5%. Moreover, it is estimated that the market will grow to be worth $1 billion annually, relatively soon.

With that considered, should Neutrolin continue to produce positive results and receive regulatory approval, the CRMD could be sitting on a figurative gold mine. Considering that multiple clinical trials have proven a redduction of risk of catheter-related infections.

While there are already options on the market that are used regularly in the space, study data suggests that Neutrolin could be the superior option.

It’s also worth looking at the stock chart over the past six months. While we’ve seen plenty of peaks and valleys, the overall trend on the stock has been up. With positive clinical data, strong IP, and many coming catalysts to support the continued growth, CRMD may see an incredible rise in value ahead.

 

[Tug life]

POTENTIAL RISK

Even though there is a ton of upside we wouldn't be intelligent investors if we didn't research the risk.

One of the biggest risk we face is having to do another phase 3 trail. There is a new FDA commissioner and he is rumored to be a bit more conservative than the last guy, and some people think giving approval on a halted phase 3 would not be conservative. Also some people fear that the reason Cormedix is doing the reverse split is to prevent the share to falling under $1 and facing delisting if another trail is needed and the stock crashes

I definitely take these factors into consideration and protect myself accordingly. But the flip side of those arguments is that the board voted to approve the 5 for 1 stock split last year in November, and that was before they met with the FDA. I believe if they felt they would have to do another trail they would have used it a long time ago, but they always had the option to use it and kept it in the back pocket and decided to use it at a time where they didn't need to while also announcing it 2 weeks before instead of just a couple of days or the night before like some companies. Also the new FDA commissioner Ned Sharpless is a biotech veteran who is also an oncologist which is the field CRMD is in, so I believe he would definitely understand the need to get this on the market. Plus the data is astoundingly good, but you can never be too sure with the FDA

 

[ORDER_66]

Wonder what's it gonna be like tomorrow...

 

[Tug life]

Wonder what's it gonna be like tomorrow...

I copped more around $1.50 today. People are selling off because of the Reverse split news. Funny how large buys came in at after hours and pushed it up to $1.61 from being at $1.51 all day

 

[Tug life]

@KING WILL any biotech stocks you're watching right now? I remember you caught Amarin and BPTH before they took off.

Im also looking at Avinger AVGR. Seeking FDA approval with a drug thats legal in China and Europe bought it at 68 cents last week and its been playing with $1 on a run up on speculation that news can drop and day

 

[KING WILL]

Great Post. Up 8%this morning! One of my FB friends mentioned this stock not that long ago. Might be gaining some traction here soon.

ATM I dont any biotech in my sights, but I might throw a few bucks at this one.

Thanks for the drop!

 

[Tug life]

A CRMD insider purchased 42,000 shares on Monday. I keep telling people Insiders and institutions are gonna buy up shares from shaky hands. Insider buys are always a good sign. Look at the top line

 

[ViShawn]

I get so wary of industries I know little about but I like what they are doing. I need to invest in less tech stocks and more stuff like this.

 

[Tug life]

I get so wary of industries I know little about but I like what they are doing. I need to invest in less tech stocks and more stuff like this.

I never understood biotech and pharmaceutical companies until I invested in Cormedix. I initially invested because I heard they got fast tracked by the FDA and that the product was selling already in Europe and just held it. I was gonna sell at one point when I was cleaning up my portfolio until I did more research and seen all the positives and the major upside. I decided to start a large position so I had to do research to make sure I was making a good investment.

Investing in CRMD, I really understood the Warren Buffett and Charlie Munger approach and looking at it as im buying a business and not just the stock. This is the only stock that I dont care about the daily price, and when it goes down im happy because I can by more for cheap. That's because im here for FDA approval or buyout. Like I said I do research on this every single day to the point I now know the full process for a company to get FDA approval

 

[Tug life]

Another CRMD insider buy has been reported. Its by director Myron Kaplan for 20,000 shares. Im going to be watching closely to the filings in the next couple of weeks. They are also buying on the open market, insider buys and sells are a key indicator on how confident the company is about the future. Cormedix is being extremely bullish in my opinion.
https://www.nasdaq.com/symbol/crmd/insider-trades

 

[ViShawn]

@GreenGhxst

 

[Starski]

What trading system do u guys use? And recommend for a beginner?

 

[Ghostface Trillah]

What trading system do u guys use? And recommend for a beginner?

Robinhood. It's free trades which every beginning needs because you're going to need it to build a good position without killing yourself at the same time.